Loading...
Market
Public approval changes for Biden administration post-reclassification
5
Resolution / Starting Odds
Increase in approval • 25%
Decrease in approval • 25%
No significant change • 25%
Cannot determine due to mixed responses • 25%
Major public polling organizations
Story
Biden Administration Proposes Reclassifying Marijuana as Schedule III Drug on Thursday
May 16, 2024, 06:41 PM
The U.S. Justice Department has formally proposed a rule on Thursday to reclassify marijuana from a Schedule I to a Schedule III drug, marking a historic shift in U.S. drug policy. This reclassification acknowledges the medical uses of cannabis and its lower potential for abuse compared to other Schedule I substances like heroin and LSD. The proposal, endorsed by President Biden, aims to ease federal restrictions on marijuana, enabling more research into its medicinal benefits. The rule is subject to a 60-day public comment period and requires final approval from the DEA. Attorney General Merrick Garland has initiated this process, and the Biden-Harris administration emphasizes its commitment to addressing past injustices related to marijuana policy.
View original story
Similar markets
Increase • 33%
Decrease • 33%
No significant change • 34%
Increase • 33%
Decrease • 33%
No Change • 34%
Increase in approval rating • 33%
Decrease in approval rating • 33%
No significant change • 34%
Increase in approval • 33%
Decrease in approval • 33%
No significant change • 34%
Significant Increase in Disapproval • 33%
No Significant Change • 33%
Significant Increase in Approval • 33%
Increase by more than 5% • 33%
Decrease by more than 5% • 33%
No significant change (+/- 5%) • 33%
Approval Increase • 25%
Approval Decrease • 25%
Approval Stays the Same • 25%
Approval Fluctuates Significantly • 25%
Significant increase • 25%
Significant decrease • 25%
No significant change • 25%
Initial dip then recovery • 25%
Increased Approval • 33%
Decreased Approval • 33%
No Significant Change • 34%
Significantly more favorable • 25%
Somewhat more favorable • 25%
No significant change • 25%
Less favorable • 25%
Increase • 33%
Decrease • 33%
Remain the same • 34%
Approval rating increases • 33%
Approval rating decreases • 33%
No significant change in approval rating • 34%